|Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter|
A Stevens, J Soden, PE Brenchley, S Ralph, DW Ray
Cancer research 63 (4), 812-816, 2003
|The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines|
JE Gibbs, J Blaikley, S Beesley, L Matthews, KD Simpson, SH Boyce, ...
Proceedings of the National Academy of Sciences 109 (2), 582-587, 2012
|The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study|
A Gupta, AJ Silman, D Ray, R Morriss, C Dickens, GJ MacFarlane, ...
Rheumatology 46 (4), 666-671, 2007
|Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency|
N Draper, EA Walker, IJ Bujalska, JW Tomlinson, SM Chalder, W Arlt, ...
Nature genetics 34 (4), 434-439, 2003
|Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile …|
R Donn, Z Alourfi, F De Benedetti, C Meazza, E Zeggini, M Lunt, ...
Arthritis & Rheumatism 46 (9), 2402-2409, 2002
|Pituitary cytokine and growth factor expression and action|
D Ray, S Melmed
Endocrine Reviews 18 (2), 206-228, 1997
|Moderation of psychosocial risk factors through dysfunction of the hypothalamic–pituitary–adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings …|
J McBeth, AJ Silman, A Gupta, YH Chiu, D Ray, R Morriss, C Dickens, ...
Arthritis & Rheumatism 56 (1), 360-371, 2007
|Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes|
D Ray, M Mishra, S Ralph, I Read, R Davies, P Brenchley
Diabetes 53 (3), 861-864, 2004
|An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action|
J Gibbs, L Ince, L Matthews, J Mei, T Bell, N Yang, B Saer, N Begley, ...
Nature medicine 20 (8), 919-926, 2014
|Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis|
WG Dixon, M Abrahamowicz, ME Beauchamp, DW Ray, S Bernatsky, ...
Annals of the rheumatic diseases 71 (7), 1128-1133, 2012
|Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study|
YH Chiu, AJ Silman, GJ MacFarlane, D Ray, A Gupta, C Dickens, ...
Pain 115 (3), 316-321, 2005
|Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents|
J McBeth, YH Chiu, AJ Silman, D Ray, R Morriss, C Dickens, A Gupta, ...
Arthritis research & therapy 7 (5), R992, 2005
|EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases|
N Duru, MC Van Der Goes, JWG Jacobs, T Andrews, M Boers, ...
Annals of the rheumatic diseases 72 (12), 1905-1913, 2013
|Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype|
A Stevens, DW Ray, E Zeggini, S John, HL Richards, CEM Griffiths, ...
The Journal of Clinical Endocrinology & Metabolism 89 (2), 892-897, 2004
|Salivary cortisone is a potential biomarker for serum free cortisol|
I Perogamvros, BG Keevil, DW Ray, PJ Trainer
The Journal of Clinical Endocrinology & Metabolism 95 (11), 4951-4958, 2010
|Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits|
JM Lane, J Liang, I Vlasac, SG Anderson, DA Bechtold, J Bowden, ...
Nature genetics 49 (2), 274, 2017
|Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank|
JM Lane, I Vlasac, SG Anderson, SD Kyle, WG Dixon, DA Bechtold, S Gill, ...
Nature communications 7 (1), 1-10, 2016
|Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study|
KA Davies, GJ Macfarlane, BI Nicholl, C Dickens, R Morriss, D Ray, ...
Rheumatology 47 (12), 1809-1813, 2008
|Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an …|
C Strehl, JWJ Bijlsma, M de Wit, M Boers, N Caeyers, M Cutolo, ...
Annals of the rheumatic diseases 75 (6), 952-957, 2016
|Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.|
DW Ray, SG Ren, S Melmed
The Journal of clinical investigation 97 (8), 1852-1859, 1996